Grant

Catalyze: Product Definition for Small Molecules, Biologics and Combination Products - Target Identification and Validation, and Preliminary Product/Lead Series Identification (R61/R33 Clinical Trials Not Allowed)

CountryUnited States
Deadline2027-12-23 (396 days left)
Published2024-11-22
SectorsHealth & life sciences
SourceGrants.gov (US)

Summary

Funding opportunity RFA-HL-26-017. CFDA: 93.838, 93.233, 93.839, 93.855, 93.837

The buyer, the value, the full description and the link to the official notice are available with a free account.